Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hedan Capsules in overweight/obese type 2 diabetes with hypertriglyceridemia
ChiCTR2300073388Phase 4Not yet recruiting
- Sponsor
- Fuwai Hospital
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM), hypertriglyceridemia, Overweight and 2 more comparing Hedan Capsules with Placebo (2 arms). Primary endpoint: Four items of blood lipid. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
Hedan
03
Conditions
type 2 diabetes mellitus (T2DM)hypertriglyceridemiaOverweightobesitydyslipidemia
Beyond the preview
Go deeper on ChiCTR2300073388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073388.